Advertisement
CME vs NDAQ
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CME is a Hold and NDAQ is a Hold.
CME in upward trend: 10-day moving average broke above 50-day moving average on October 14, 2026
The 10-day moving average for CME crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CME as a result. In 57 of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for CME just turned positive on October 08, 2026. Looking at past instances where CME's MACD turned positive, the stock continued to rise in 22 of 47 cases over the following month. The odds of a continued upward trend are 47%.
CME moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in 170 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
CME broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CME entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 23 (best 1 - 100 worst), indicating outstanding price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.149) is normal, around the industry mean (4.019). P/E Ratio (25.821) is within average values for comparable stocks, (17.786). CME's Projected Growth (PEG Ratio) (4.578) is very high in comparison to the industry average of (1.780). Dividend Yield (0.017) settles around the average of (0.019) among similar stocks. CME's P/S Ratio (14.535) is slightly higher than the industry average of (7.166).
NDAQ in upward trend: price rose above 50-day moving average on October 20, 2026
NDAQ moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on NDAQ as a result. In 49 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for NDAQ just turned positive on October 09, 2026. Looking at past instances where NDAQ's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.
The 10-day moving average for NDAQ crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +8.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where NDAQ advanced for three days, in 224 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NDAQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
NDAQ broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NDAQ entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 33 (best 1 - 100 worst), indicating outstanding price growth. NDAQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.817) is normal, around the industry mean (4.019). P/E Ratio (29.855) is within average values for comparable stocks, (17.786). Projected Growth (PEG Ratio) (1.712) is also within normal values, averaging (1.780). Dividend Yield (0.012) settles around the average of (0.019) among similar stocks. P/S Ratio (5.831) is also within normal values, averaging (7.166).
CME | NDAQ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | 89 Overvalued | |
PROFIT vs RISK RATING 1..100 | 34 | 23 | |
SMR RATING 1..100 | 54 | 52 | |
PRICE GROWTH RATING 1..100 | 23 | 33 | |
P/E GROWTH RATING 1..100 | 41 | 47 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NDAQ's Valuation (89) in the Investment Banks Or Brokers industry is in the same range as CME (97). This means that NDAQ’s stock grew similarly to CME’s over the last 12 months.
NDAQ's Profit vs Risk Rating (23) in the Investment Banks Or Brokers industry is in the same range as CME (34). This means that NDAQ’s stock grew similarly to CME’s over the last 12 months.
NDAQ's SMR Rating (52) in the Investment Banks Or Brokers industry is in the same range as CME (54). This means that NDAQ’s stock grew similarly to CME’s over the last 12 months.
CME's Price Growth Rating (23) in the Investment Banks Or Brokers industry is in the same range as NDAQ (33). This means that CME’s stock grew similarly to NDAQ’s over the last 12 months.
CME's P/E Growth Rating (41) in the Investment Banks Or Brokers industry is in the same range as NDAQ (47). This means that CME’s stock grew similarly to NDAQ’s over the last 12 months.
| CME | NDAQ | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 48% | 1 day ago 56% |
| Stochastic ODDS (%) | 1 day ago 46% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 54% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 47% | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 52% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 53% | 1 day ago 62% |
| Advances ODDS (%) | 1 day ago 50% | 1 day ago 63% |
| Declines ODDS (%) | 23 days ago 41% | 9 days ago 51% |
| BollingerBands ODDS (%) | 1 day ago 51% | 1 day ago 53% |
| Aroon ODDS (%) | 1 day ago 34% | 1 day ago 52% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CME’s FA Score shows that 1 FA rating(s) are green while NDAQ’s FA Score has 2 green FA rating(s).
- CME’s FA Score: 1 green, 4 red.
- NDAQ’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CME’s TA Score shows that 5 TA indicator(s) are bullish while NDAQ’s TA Score has 5 bullish TA indicator(s).
- CME’s TA Score: 5 bullish, 5 bearish.
- NDAQ’s TA Score: 5 bullish, 5 bearish.
Price Growth
CME (@Financial Publishing/Services) experienced а +3.57% price change this week, while NDAQ (@Financial Publishing/Services) price change was +4.52% for the same time period.
The average weekly price growth across all stocks in the @Financial Publishing/Services industry was +2.74%. For the same industry, the average monthly price growth was +6.15%, and the average quarterly price growth was +8.53%.
Reported Earning Dates
CME is expected to report earnings on Feb 10, 2027.
NDAQ is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Financial Publishing/Services (+2.74% weekly)The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.
Advertisement
CME and
Correlation & Price change
A.I.dvisor indicates that over the last year, CME has been loosely correlated with ICE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CME jumps, then ICE could also see price increases.
| Ticker / NAME | Correlation To CME | 1D Price Change % | ||
|---|---|---|---|---|
| CME | 100% | +3.45% | ||
| ICE - CME | 49% Loosely correlated | +3.90% | ||
| TW - CME | 45% Loosely correlated | +1.57% | ||
| NDAQ - CME | 36% Loosely correlated | +7.47% | ||
| MKTX - CME | 35% Loosely correlated | +0.24% | ||
| MSCI - CME | 26% Poorly correlated | +2.61% | ||
More | ||||
NDAQ and
Correlation & Price change
A.I.dvisor indicates that over the last year, NDAQ has been closely correlated with JEF. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if NDAQ jumps, then JEF could also see price increases.
| Ticker / NAME | Correlation To NDAQ | 1D Price Change % | ||
|---|---|---|---|---|
| NDAQ | 100% | +7.47% | ||
| JEF - NDAQ | 71% Closely correlated | +1.35% | ||
| MS - NDAQ | 71% Closely correlated | -1.63% | ||
| GS - NDAQ | 70% Closely correlated | -1.48% | ||
| RJF - NDAQ | 69% Closely correlated | +2.25% | ||
| SF - NDAQ | 66% Closely correlated | +2.17% | ||
More | ||||